Connect with others who understand.

Sign up Log in
Resources
About MyMSTeam
Powered By
See answer

FDA Approves 10-Minute Injectable Version of Ocrevus

Written by Ted Samson
Posted on November 6, 2024

The U.S. Food and Drug Administration (FDA) has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq). It’s a twice-a-year, 10-minute subcutaneous (under the skin) injection version of Ocrevus. Like Ocrevus, Ocrevus Zunovo is for people with relapsing multiple sclerosis and primary progressive multiple sclerosis.

The original version of Ocrevus is administered as an IV infusion, requiring at least two hours per visit, twice a year at a specialized infusion center. This new version is given as a quick injection in the abdomen by a health care professional at a doctor’s office or clinic.

Ocrelizumab, the active ingredient in Ocrevus, works by targeting CD20-positive B cells, a type of immune cell thought to contribute to nerve damage in MS. The addition of hyaluronidase-ocsq enhances absorption, allowing the medication to be given subcutaneously rather than intravenously.

Trial results show that Ocrevus Zunovo is as effective as the IV version of ocrelizumab in suppressing relapses and lesions seen on MRI by 97 percent over 48 weeks. Most trial participants also reported high satisfaction with the convenience of quicker injections.

A Faster, More Convenient Approach

Ocrevus Zunovo could be helpful for people seeking alternatives to lengthy IV infusions at specialized infusion centers. The injection works just as well while offering more flexibility and shorter administration time. Since it can be given in a doctor’s office, it may reduce travel times for those who don’t live near an infusion center. If you have questions about advances in MS treatments, talk to your neurologist.

Here are eight facts about the risks and benefits of infusion therapy for MS.

Find Your Team

On MyMSTeam, the social network for people living with multiple sclerosis and their loved ones, members come together to ask questions, give advice, and share their stories with others who understand life with MS.

Would you prefer an at-home injection or infusions in a clinic? Share your tips and experiences in a comment below, start a conversation on your Activities page, or connect with like-minded people in Groups.

Ted Samson is a copy editor at MyHealthTeam. Learn more about him here.

A MyMSTeam Member

I also have secondary progressive but was declined because of my age. I am 62.

November 25
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy

How Does The Price Compare To The IV Series?

November 15, 2024 by A MyMSTeam Member 3 answers

My Dr Tried To Get Me On Ocrevus But Unfortunately The Drug Is Only Approved For People 55 And Younger.??? Is The New Drug The Same?

November 23, 2024 by A MyMSTeam Member 8 answers

Wonder If The Injection Will Have The Same Side Effects As The Infusions. Two Days After The Infusions If Feel Completely Exhausted, Like

November 25, 2024 by A MyMSTeam Member 3 answers

Thank you for subscribing!

Become a member to get even more: